Historical record - last NADAC effective date: 6/19/2024
Product Information
DELSYM COUGH+CHEST CNGST DM LQ is a brand product labeled by RB Health (US) LLC, priced at $0.0614 per ML under NDC 63824021366. Its NADAC has been published 458 times since Apr 16, 2014.
Strength
20; 400 mg/20mL; mg/20mL
Manufacturer
RB Health (US) LLCNDC
63824021366
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/31/2013
Pharmacological Classes
Price Statistics
The NADAC for DELSYM COUGH+CHEST CNGST DM LQ has been published 458 times since Apr 16, 2014, and over the history we have for it it has risen 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0614 per ML |
|---|---|
| All-time high | $0.0639 (Jun 29, 2022) |
| All-time low | $0.0456 (Apr 16, 2014) |
| Median price | $0.0527 |
| Average price | $0.0521 |
| Largest weekly change | +16.7% (Apr 6, 2022) |
| Weeks tracked | 458 |
| Tracking since | Apr 16, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-4.0%
5Y
+15.4%
All
+34.6%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RB Health (US) LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan Hydrobromide and Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DELSYM COUGH+CHEST CNGST DM LQ?
The current National Average Drug Acquisition Cost (NADAC) for DELSYM COUGH+CHEST CNGST DM LQ, manufactured by RB Health (US) LLC, is $0.0614 per ML (NDC 63824021366), effective Jul 3, 2024.
How has the price of DELSYM COUGH+CHEST CNGST DM LQ changed over time?
Over the history we have for it, the NADAC for DELSYM COUGH+CHEST CNGST DM LQ has risen 34.6%. It has been tracked across 458 weekly CMS publications since Apr 16, 2014.
What are the highest and lowest recorded NADAC prices for DELSYM COUGH+CHEST CNGST DM LQ?
Since Apr 16, 2014, the NADAC for DELSYM COUGH+CHEST CNGST DM LQ has ranged from a low of $0.0456 (Apr 16, 2014) to a high of $0.0639 (Jun 29, 2022), with a median of $0.0527 per ML.
Are there cheaper alternatives to DELSYM COUGH+CHEST CNGST DM LQ?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DELSYM COUGH+CHEST CNGST DM LQ in a comparable dosage form, but none are currently priced below it.
Who manufactures DELSYM COUGH+CHEST CNGST DM LQ?
DELSYM COUGH+CHEST CNGST DM LQ (NDC 63824021366) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.